UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Numerical simulation and experimental investigation on powder transport of a new-type annular coaxial nozzle

International journal of advanced manufacturing technology, 2021-08, Vol.115 (7-8), p.2353-2364

2021

Volltextzugriff (PDF)

Additive manufacturing of tantalum-zirconium alloy coating for corrosion and wear application by laser directed energy deposition on Ti6Al4V

Surface & coatings technology, 2021-04, Vol.411, p.127006, Article 127006

2021

Volltextzugriff (PDF)

Experiments and numerical simulations for the mechanical properties of Ni-based superalloys fabricated by laser melting deposition

Optics and laser technology, 2021-08, Vol.140, p.107058, Article 107058

2021

Volltextzugriff (PDF)

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

Frontiers in oncology, 2021-04, Vol.11, p.562315-562315

2021

Volltextzugriff (PDF)

Comparative effectiveness of pembrolizumab vs. nivolumab in patients with recurrent or advanced NSCLC

Scientific reports, 2020-08, Vol.10 (1), p.13160-13160, Article 13160

2020

Volltextzugriff (PDF)

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors

Clinical Medicine Insights. Oncology, 2021, Vol.15, p.1179554921996288-1179554921996288

2021

Volltextzugriff (PDF)

The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors

Frontiers in oncology, 2022-10, Vol.12, p.887383-887383

2022

Volltextzugriff (PDF)

Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma

Journal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.881-891

2021

Volltextzugriff (PDF)

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920922033-1758835920922033

2020

Volltextzugriff (PDF)

Analysis of the causes and influencing factors of fetal loss in advanced maternal age: a nested case-control study

BMC pregnancy and childbirth, 2021-08, Vol.21 (1), p.1-538, Article 538

2021

Volltextzugriff (PDF)

Random Forest Model for Labor Induction in Pregnant Women With Hypertensive Disorders Using a Cervical Double Balloon

Alternative therapies in health and medicine, 2023-01, Vol.29 (1), p.44

2023

Volltextzugriff (PDF)

Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting

Cancer Immunology, Immunotherapy, 2021-10, Vol.70 (10), p.2971-2980

2021

Volltextzugriff (PDF)

Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer

Targeted oncology, 2020-02, Vol.15 (1), p.93-100

2020

Volltextzugriff (PDF)

Effect of Emi1 gene silencing on the proliferation and invasion of human breast cancer cells

BMC molecular and cell biology, 2023-12, Vol.24 (1), p.34-34, Article 34

2023

Volltextzugriff (PDF)

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT

BMC cancer, 2019-06, Vol.19 (1), p.606-606, Article 606

2019

Volltextzugriff (PDF)

A More Universal Approach to Comprehensive Analysis of Thalassemia Alleles (CATSA)

The Journal of molecular diagnostics : JMD, 2021-09, Vol.23 (9), p.1195-1204

2021

Volltextzugriff (PDF)

Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults

Vaccine, 2023-07, Vol.41 (34), p.4978-4985

2023

Volltextzugriff (PDF)

A novel variant c.902C>A (p. A301D) in KCNQ4 associated with non‐syndromic deafness 2A in a Chinese family

Molecular genetics & genomic medicine, 2024-07, Vol.12 (7), p.e2446-n/a

2024

Volltextzugriff (PDF)

Prenatal diagnosis of fetal digestive system malformations and pregnancy outcomes at a tertiary referral center in Fujian, China: A retrospective study

Heliyon, 2023-11, Vol.9 (11), p.e21546-e21546, Article e21546

2023

Volltextzugriff (PDF)

Circular RNA hsa_circ_0119412 contributes to tumorigenesis of gastric cancer via the regulation of the miR-1298-5p/zinc finger BED-type containing 3 (ZBED3) axis

Bioengineered, 2022-03, Vol.13 (3), p.5827-5842

2022

Volltextzugriff (PDF)

Clinical outcomes of surgical resection vs yttrium 90 radioembolization (Y90) in hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI)

Journal of hepatology, 2023-06, Vol.78, p.S591-S592

2023

Volltextzugriff (PDF)

Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer

Journal of surgical oncology, 2018-03, Vol.117 (4), p.692-698

2018

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(30)
Chinesisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Numerical simulation and experimental investigation on powder transport of a new-type annular coaxial nozzle

Additive manufacturing of tantalum-zirconium alloy coating for corrosion and wear application by laser directed energy deposition on Ti6Al4V

Experiments and numerical simulations for the mechanical properties of Ni-based superalloys fabricated by laser melting deposition

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

Comparative effectiveness of pembrolizumab vs. nivolumab in patients with recurrent or advanced NSCLC

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors

The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors

Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

Analysis of the causes and influencing factors of fetal loss in advanced maternal age: a nested case-control study

Random Forest Model for Labor Induction in Pregnant Women With Hypertensive Disorders Using a Cervical Double Balloon

Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting

Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer

Effect of Emi1 gene silencing on the proliferation and invasion of human breast cancer cells

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT

A More Universal Approach to Comprehensive Analysis of Thalassemia Alleles (CATSA)

A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study

Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults

A novel variant c.902C>A (p. A301D) in KCNQ4 associated with non‐syndromic deafness 2A in a Chinese family

Prenatal diagnosis of fetal digestive system malformations and pregnancy outcomes at a tertiary referral center in Fujian, China: A retrospective study

Circular RNA hsa_circ_0119412 contributes to tumorigenesis of gastric cancer via the regulation of the miR-1298-5p/zinc finger BED-type containing 3 (ZBED3) axis

Clinical outcomes of surgical resection vs yttrium 90 radioembolization (Y90) in hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI)

THU-142 - Clinical outcomes of surgical resection vs yttrium 90 radioembolization (Y90) in hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI)

A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric adenocarcinoma: the NeoRacing study

Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer

Suchergebnisse filtern